CURRENT APPROACHES AND NEW RESEARCH IN
MODERN SCIENCES
International scientific-online conference
78
INTERNATIONAL LEGAL REGULATION OF NEW SYNTHETIC
DRUGS: CHALLENGES, DEVELOPMENTS, AND PROSPECTS
Abdusattorov Shakhzod Abdumumin ugli
lecturer of the Department of International
Private Law of the Tashkent State University of Law.
E-mail: shekhzadtashqirasmiy@gmail.com
https://doi.org/10.5281/zenodo.15654213
Annotation
. The emergence and rapid proliferation of new synthetic drugs
(NSDs), also known as new psychoactive substances (NPS), present one of the
most pressing legal and public health challenges of the 21st century. These
substances often mimic the effects of traditional narcotics but evade control due
to structural novelty. This article provides a comprehensive analysis of the
international legal regulation of NSDs, assessing current frameworks such as the
UN drug control conventions, regional mechanisms in the European Union, and
national models in countries like the United States, China, and Uzbekistan.
Particular focus is given to the gaps in legal response, issues of jurisdiction, and
the dynamic nature of drug design. The paper concludes by offering policy
recommendations for a more effective, science-based, and human rights-
compliant global drug control regime.
Keywords
: New synthetic drugs (NSDs); new psychoactive substances
(NPS); international drug control; UNODC; legal regulation; transnational crime;
scheduling; public health; criminal law; legal harmonization.
Introduction
. The globalization of narcotic trade has evolved into a far
more complex phenomenon with the advent of new synthetic drugs (NSDs).
These substances are chemically engineered to replicate or enhance the
psychoactive effects of controlled narcotics, while often avoiding legal scrutiny
due to their novel structure.
1
This paper examines the international legal
landscape surrounding the regulation of NSDs and evaluates whether existing
instruments remain fit for purpose.
The Emergence of New Synthetic Drugs: A Global Threat. The United
Nations Office on Drugs and Crime
2
defines NSDs as "substances of abuse, either
in a pure form or a preparation, that are not controlled by international drug
conventions but pose a public health threat." More than 1,100 such substances
have been identified since 2009. Their rapid evolution and online dissemination
through the darknet exacerbate the challenge.
CURRENT APPROACHES AND NEW RESEARCH IN
MODERN SCIENCES
International scientific-online conference
79
The 1961, 1971, and 1988 UN Drug Conventions. The three core
international drug control treaties—the Single Convention on Narcotic Drugs
(1961), the Convention on Psychotropic Substances (1971), and the United
Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic
Substances (1988)—form the foundation of international drug law. However,
these instruments are ill-equipped to address the fluid nature of NSDs.
3
The
International Narcotics Control Board (INCB) and UNODC monitor
implementation and provide scientific recommendations for scheduling
substances. However, the process is often criticized for being slow, politically
influenced, and reactive rather than preventive.
The European Union Legal Framework. The EU employs a faster and more
flexible early-warning system coordinated by the European Monitoring Centre
for Drugs and Drug Addiction (EMCDDA). The EU Regulation 2017/2101
introduced an expedited assessment and control procedure.
4
Southeast Asian
nations, under ASEAN coordination, have adopted regional declarations but lack
enforceable legal harmonization. African countries, on the other hand, face
severe gaps in surveillance and enforcement capacities.
5
United States (Controlled Substances Analogue Enforcement Act). The U.S.
adopted the Analogue Act (1986) to treat structurally similar substances to
scheduled drugs as illegal. The Act’s vagueness, however, has faced
constitutional challenges (United States v. McFadden, 2015). China’s “class-
based” or “pre-listing” model enables authorities to control entire classes of
substances based on core molecular structures,
6
an approach praised for its
proactive orientation.
Uzbekistan: Legal Reforms and International Commitments. Uzbekistan has
been modernizing its drug laws in alignment with UN conventions. The 2021
reform introduced accelerated administrative controls over substances flagged
by the UNODC, while initiating cooperation with Interpol and EMCDDA. The time
lag between identification and control remains critical. The average time from
identification of an NSD to its scheduling under the UN conventions is over two
years.
7
Jurisdictional conflicts arise in cyberspace-related trafficking. A synthetic
drug produced in one country, sold on the darknet from another, and consumed
in a third poses challenges for enforcement. Punitive drug laws have led to mass
incarceration and human rights violations in various jurisdictions. The UN
CURRENT APPROACHES AND NEW RESEARCH IN
MODERN SCIENCES
International scientific-online conference
80
Special Rapporteur has urged nations to ensure proportionality and non-
discrimination in drug control efforts.
Comparative Analysis of Best Practices. The combination of China’s pre-
listing model, the EU’s early warning and risk assessment network, and the U.S.
rapid response analog legislation represents a hybrid model of good practice.
However, integration of public health strategies remains insufficient globally.
Towards a Dynamic Scheduling System. Experts advocate a “dynamic
scheduling” system using AI tools to flag potential analogues based on molecular
structures, streamlining the decision-making process (WHO, 2023). A UN-
mandated global database that tracks NPS trade in real-time and facilitates
coordination among customs, police, and health authorities is needed to replace
the fragmented system. The WHO (2023) recommends that drug control
measures be embedded within public health systems, focusing on harm
reduction, treatment access, and youth education.
Conclusions and Policy Recommendations
. The regulation of NSDs
requires urgent legal reform. The current international framework is too static
and too slow to respond to the ever-evolving nature of synthetic drugs. It must
evolve into a dynamic, science-led, and human-rights-centered system. Key
recommendations include:
Reform of the scheduling procedure at the UN level to include emergency
listings;
Promotion of flexible national models such as class-based or analogue-
based controls;
Regional data-sharing hubs and cross-border taskforces;
Increased investment in public health infrastructure and harm-reduction
services;
Embedding human rights safeguards into national drug laws.
References:
1. African Union. (2021). Continental Plan of Action on Drug Control and Crime
Prevention (2019–2023). African Union Commission.
2. Bewley-Taylor, D., & Jelsma, M. (2021). Scheduling in the international drug
control system: Critical gaps and reform proposals. Global Drug Policy
Observatory.
3. EMCDDA. (2021). New psychoactive substances in Europe: Legislation and
legal responses. European Monitoring Centre for Drugs and Drug Addiction.
4. Hallam, C., & Bewley-Taylor, D. (2023). Recalibrating Drug Control: A
Balanced Approach. Transnational Institute.
CURRENT APPROACHES AND NEW RESEARCH IN
MODERN SCIENCES
International scientific-online conference
81
5. UNODC. (2022). World Drug Report 2022. United Nations Office on Drugs and
Crime.
6. UNODC. (2023). Synthetic Drugs in East and Southeast Asia: Latest
Developments and Challenges. Vienna: UNODC Global SMART Programme.
7. United Nations Human Rights Council. (2022). Report of the Special
Rapporteur on the right to health and drug policy.
8. United States v. McFadden, 576 U.S. 186 (2015).
9. WHO. (2023). Health and Human Rights Approaches to Drug Control Policy:
Expert Guidance. World Health Organization.
10. Zhou, Y., & Liang, H. (2022). “China’s Legislative Model on Synthetic Drugs
Control.” Asian Journal of Criminology, 17(1), 35–57.
